Sopharma AD participated in the capital increase of Doverie Obedinen Holding AD and acquired 1 405 889 shares from the capital increase. As a result Sopharma AD has crossed the threshold of 15% in the capital of Doverie Obedinen Holding AD and now owns 18.697%.
The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 02 August 2012 up to and including 08 August 2012 the Company bought 4266 own shares representing 0.00323% of the share capital of the Company, at a total value of BGN 10025.00 on the Bulgarian Stock Exchange. The average price per share was BGN 2.35.
The shares have been bought on the basis of the general meeting resolution of 23.06.2010.
The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 09 August 2012 up to and including 15 August 2012 the Company bought 2200 own shares representing 0.0017% of the share capital of the Company, at a total value of BGN 5320.76 on the Bulgarian Stock Exchange. The average price per share was BGN 2.42.
The shares have been bought on the basis of the general meeting resolution of 23.06.2010.
The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that Sopharma AD will commence the paying of dividends for 2011 on 31 August 2012 in accordance with a List of Entitled Persons as at 13 July 2012, prepared by the Central Depository.
The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 16. August 2012 up to and including 22. August 2012 the Company bought 11650 own shares representing 0.0088% of the share capital of the Company, at a total value of BGN 28325.60 on the Bulgarian Stock Exchange. The average price per share was BGN 2.431.
The shares have been bought on the basis of the general meeting resolution of 23. June 2010.
The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 23 August 2012 up to and including 29 August 2012 the Company bought 10111 own shares representing 0.0077% of the share capital of the Company, at a total value of BGN 24700.46 on the Bulgarian Stock Exchange. The average price per share was BGN 2.44.
The shares have been bought on the basis of the general meeting resolution of 23. June 2010.
We would like to notify that for the month of August 2012 "Sopharma" AD recorded a decline in sales of 6% compared to the same month of the previous year, including an 8% drop in export sales and a 1% increase in domestic sales.
Revenue from sales in the first eight months of the current year rose by 2%, including a 10% decline for the domestic market and an 8% increase in exports compared to the same period in 2011.
The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that between 29 August 2012 and 05 September 2012, including, the Company bought back 18746 own shares representing 0.0142% of the share capital of the Company, at a total value of BGN 45675.09 on the Bulgarian Stock Exchange. The average price per share was BGN 2.44.
The shares have been bought on the basis of the decision of the General Meeting of Shareholders from 23 June 2010.
The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 5 September 2012 up to and including 12 September 2012 the Company bought 100 own shares representing 0.000076% of the share capital of the Company, to the total value of BGN 241.00 on the Bulgarian Stock Exchange. The average price per share was BGN 2.41.
The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.
The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 13 September 2012 up to and including 19 September 2012 the Company bought 550 own shares representing 0.00042% of the share capital of the Company, to the total value of BGN 1330.00 on the Bulgarian Stock Exchange. The average price per share was BGN 2.418.
The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.
